Valuation Macro Group Pharmaceuticals (Macro Capital) S.A.E
Stocks
MCRO
EGS7D971C011
Pharmaceuticals
|
End-of-day quote
Egyptian Exchange
10/11/2026
|
5-day change | 1st Jan Change | ||
| 1.420 EGP | +5.19% |
|
+10.08% | +24.56% |
Company Valuation: Macro Group Pharmaceuticals (Macro Capital) S.A.E
Data adjusted to current consolidation scope
| Fiscal Period: December | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| Market Cap 1 | 650 | 4,858 | - | - |
| Change | - | 647.37% | - | - |
| Enterprise Value (EV) 1 | 650 | 4,778 | 4,748 | 4,590 |
| Change | - | 635.11% | -0.63% | -3.33% |
| P/E | 5.7x | 23.7x | 15.8x | 12.9x |
| PBR | - | 8.35x | 6.45x | 5.26x |
| PEG | - | -0.3x | 0.3x | 0.6x |
| Capitalization / Revenue | - | 4.08x | 3.13x | 2.5x |
| EV / Revenue | - | 4.02x | 3.06x | 2.36x |
| EV / EBITDA | - | 17.6x | 12.5x | 9.11x |
| EV / EBIT | - | 19.9x | 14.1x | 10.3x |
| EV / FCF | - | 101x | 26.5x | 13.3x |
| FCF Yield | - | 0.99% | 3.77% | 7.54% |
| Dividend per Share 2 | - | 0.03 | 0.04 | 0.06 |
| Rate of return | - | 2.11% | 2.82% | 4.23% |
| EPS 2 | 0.2 | 0.06 | 0.09 | 0.11 |
| Distribution rate | - | 50% | 44.4% | 54.5% |
| Net sales 1 | - | 1,190 | 1,552 | 1,946 |
| EBITDA 1 | - | 271 | 381 | 504 |
| EBIT 1 | - | 240 | 337 | 444 |
| Net income 1 | 115.7 | 206 | 283 | 373 |
| Net Debt 1 | - | -79.7 | -110 | -268 |
| Reference price 2 | 1.140 | 1.420 | 1.420 | 1.420 |
| Nbr of stocks (in thousands) | 570,206 | 3,421,239 | - | - |
| Announcement Date | 19/02/26 | - | - | - |
1EGP in Million2EGP
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 22.5x | 3.81x | 16.75x | - | 85.71M | ||
| 41.32x | 13.98x | 29.71x | 0.48% | 1,258B | ||
| 41.29x | 6.93x | 19.48x | 1.89% | 679B | ||
| 37.78x | 8.57x | 17.7x | 2.35% | 518B | ||
| 21.56x | 5.23x | 13.1x | 2.5% | 390B | ||
| 105.59x | 6.02x | 25.64x | 2.28% | 367B | ||
| 23.81x | 5.93x | 14.32x | 2.69% | 307B | ||
| 24.64x | 4.94x | 13.88x | 1.76% | 293B | ||
| 24x | 7.37x | 13.68x | 2.17% | 252B | ||
| -39.75x | 7.37x | 46.38x | 1.95% | 210B | ||
| Average | 30.27x | 7.01x | 21.06x | 2.01% | 427B | |
| Weighted average by Cap. | 37.19x | 8.81x | 22.45x | 1.69% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MCRO Stock
- Valuation Macro Group Pharmaceuticals (Macro Capital) S.A.E
Select your edition
All financial news and data tailored to specific country editions
















